Yuhan Corporation (KRX:000100)

South Korea flag South Korea · Delayed Price · Currency is KRW
92,900
-900 (-0.96%)
At close: Apr 10, 2026
Market Cap6.91T -26.1%
Revenue (ttm)2.19T +5.7%
Net Income194.08B +174.6%
EPS2,599.51 +175.6%
Shares Out74.44M
PE Ratio35.74
Forward PE43.94
Dividend500.00 (0.53%)
Ex-Dividend DateFeb 26, 2026
Volume176,406
Average Volume210,508
Open93,900
Previous Close93,800
Day's Range92,800 - 94,100
52-Week Range90,900 - 136,400
Beta0.57
RSI41.57
Earnings DateMay 15, 2026

About Yuhan

Yuhan Corporation operates as a pharmaceutical company in South Korea and internationally. It offers manufacturing services, such as custom manufacturing; process research and development of active pharmaceutical products (APIs) and intermediates; kilo and pilot-scale production of APIs and intermediates; commercial production of APIs and intermediates; production of chemical specialties; and analytical method development and regulatory support. The company also provides APIs and intermediates, including antibiotic, anti-thrombotic, anti-hyperl... [Read more]

Sector Healthcare
Founded 1926
Employees 2,067
Stock Exchange Korea Stock Exchange
Ticker Symbol 000100
Full Company Profile

Financial Performance

In 2025, Yuhan's revenue was 2.19 trillion, an increase of 5.75% compared to the previous year's 2.07 trillion. Earnings were 194.08 billion, an increase of 174.56%.

Financial Statements